Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02861573
Brief Title: Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)

First Submitted : August 3, 2016
First Submitted that Met QC Criteria : August 5, 2016
First Posted : August 10, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : November 22, 2019
Last Update Posted : November 25, 2019